These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hypotension after quinidine plus verapamil. Possible additive competition at alpha-adrenergic receptors. Maisel AS; Motulsky HJ; Insel PA N Engl J Med; 1985 Jan; 312(3):167-70. PubMed ID: 2981405 [No Abstract] [Full Text] [Related]
24. New drugs for the treatment of cardiac arrhythmias. Bump TE; Arnsdorf MF Compr Ther; 1980 Jun; 6(6):63-72. PubMed ID: 6103779 [No Abstract] [Full Text] [Related]
25. [Anti-arrhythmic action of combinations of trimecaine with quinidine, novocainamide and cordaron (clinico-experimental study)]. Oleĭnikov VE; Tatarchenko IP; Zhivotovskaia GG Kardiologiia; 1985 Sep; 25(9):118-20. PubMed ID: 2416980 [No Abstract] [Full Text] [Related]
26. [Combined administration of diphenylhydantoin, quinidine and perazine (Phenrytmat)]. Dosch HM Med Welt; 1975 Apr; 26(15):732-4. PubMed ID: 240100 [No Abstract] [Full Text] [Related]
27. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology. Singh BN N Z Med J; 1973 Dec; 78(505):529-35. PubMed ID: 4150209 [No Abstract] [Full Text] [Related]
28. Pharmacologic basis for the treatment of cardiac arrhythmias. Gelband H; Rosen MR Pediatrics; 1975 Jan; 55(1):59-67. PubMed ID: 1089243 [No Abstract] [Full Text] [Related]
29. Combined administration of quinidine with the beta-adrenolytic agent inderal and the local anaesthetic of the beta-aminoketone group, hexacaine, in various experimental models of arrhythmias. Kudrin AN; Aslaniants ZK; Polevoi LG Cor Vasa; 1975; 17(2):133-44. PubMed ID: 1157502 [TBL] [Abstract][Full Text] [Related]
30. Clinical usefulness of the beta-adrenergic antagonists. Lubbe WF S Afr Med J; 1978 Jul; 54(4):139-48. PubMed ID: 29349 [TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction. van Dijk L Folia Med Neerl; 1971; 14(5):225-36. PubMed ID: 4400908 [No Abstract] [Full Text] [Related]
32. Sinus nodal reentry. Effect of quinidine. Paulay KL; Weisfogel GM; Damato AN Am J Cardiol; 1974 May; 33(5):617-22. PubMed ID: 4820893 [No Abstract] [Full Text] [Related]
33. Dangerous interaction between amiodarone and quinidine. Tartini R; Kappenberger L; Steinbrunn W; Meyer UA Lancet; 1982 Jun; 1(8285):1327-9. PubMed ID: 6123639 [No Abstract] [Full Text] [Related]
34. [Treatment of arrhythmia in patients with chronic ischemic heart disease using kinilentin combined with an inhibitor or inductor of microsomal oxidation]. Kharlamova IV; Sivkov II; Starodubtsev AK; Bogovskiĭ BP; Blinkov IL; Rubin MP Sov Med; 1989; (12):41-4. PubMed ID: 2631246 [No Abstract] [Full Text] [Related]
35. Correlation of electrocardiographic changes with plasma quinidine concentration. Gonzalez ER; Meyers DG Nebr Med J; 1985 Mar; 70(3):87-91. PubMed ID: 3982553 [No Abstract] [Full Text] [Related]
36. [Mechanisms of interactions of anti-arrhythmia agents during their combined use]. Adnan Abdalla ; Mazur NA; Shestakova NV Kardiologiia; 1991 Feb; 31(2):87-91. PubMed ID: 2041300 [No Abstract] [Full Text] [Related]
37. Perspectives on the current treatment of cardiac arrhythmias. Bigger JT Am J Cardiol; 1984 Aug; 54(4):2B-7B. PubMed ID: 6147081 [TBL] [Abstract][Full Text] [Related]
38. A reevaluation of intravenous quinidine. Woo E; Greenblatt DJ Am Heart J; 1978 Dec; 96(6):829-32. PubMed ID: 717247 [No Abstract] [Full Text] [Related]
39. [Combined treatment with quinidine-propranolol for arrhythmia]. Hardell LI; Warmenius S Lakartidningen; 1969 Sep; 66(38):3827-32. PubMed ID: 5384292 [No Abstract] [Full Text] [Related]
40. Once daily versus twice daily beta-blockers: effects on arrhythmias and hypertension. Frick MH; Kala R Lancet; 1980 Sep; 2(8194):588. PubMed ID: 6106763 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]